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Abstract
Endothelial function plays an important role in the extrauterine adaptation of 
newborn infants. Endothelium produces different biologically active mediators, 
which play the central role in physiological and pathological processes and also in the 
extrauterine adaptation of newborn infants. The imbalance between vasoconstric-
tive and vasodilatation factors results in impaired cardiovascular adaptation and 
microcirculation and also brain injury. Microcirculatory disturbances are observed 
very often in preterm babies, who have a serious risk for perinatal brain injury and 
further neurodevelopment disabilities. Present chapter presents the pathogenetic role 
of vascular tone regulators of endothelial genesis in the formation of microcirculatory 
changes in preterm babies with a high risk of perinatal hypoxic encephalopathy.
Keywords: microcirculation, hypoxic encephalopathy, preterm infants,  
endothelial function, nitric oxide
1. Introduction
The largest research object of modern perinatology and neonatology is preterm 
and growth retarded children. Despite the rapid development of perinatal care 
and the early prevention of many pathologies, worldwide perinatal morbidity and 
mortality remain high [1–4].
The results of the scientific researches prove that perinatal pathologies play a 
leading role in the formation of illness, death, disability, social and biological disar-
ray, and different types of neurodevelopmental disorders [5–10]. It is known that 
birth is a complicated biological process regulated by numerous signal molecules and 
biologically active substances. The fetal inflammatory response plays a major role in 
the pathogenesis of premature birth [11]. In addition to prematurity, the hypoxic-
ischemic changes in feto-placental system can result in different perinatal patholo-
gies, such as acute intraventricular bleeding, periventricular leukomalation, necrotic 
enterocolitis, bronchial lung dysplasia, myocardial dysfunction, sepsis, etc. [12–15].
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Uteroplacental ischemia and circulatory changes in maternal-fetal system are the 
main chain in formation intrauterine hypoxia and different perinatal pathologies 
[16–18]. Previous investigations confirmed the significant role of endothelial func-
tion in the formation of different pregnancy pathologies and birth defects [19–22]. 
The pathogenetic mechanisms of the formation of endothelial dysfunction during 
uteroplacental ischemia have not yet been investigated. Present chapter explores the 
role of vascular tone regulators of endothelial genesis in formation of microcircula-
tory and ischemic changes in preterm infants.
2.  The pathophysiology of brain injury in hypoxic: ischemic 
encephalopathy (HIE)
Adaptation of the child to the extrauterine life significantly depends on the 
morpho-functional maturity of the organism, and it is more intense and more 
complicated in preterm babies than mature children [23–25].
The progress of all complicated pathophysiologic processes occurring in the 
newborn after birth significantly depends on cardiorespiratory adaptation [23, 24]. 
The changes in the cardiovascular and respiratory functions in the body related to 
the primarily changes in the microcirculation [25]. Microcirculatory changes are not 
only clinical symptoms of various pathologies of perinatal period but also one of the 
major factors that aggravate their course [26, 27].
HIE is one of the most serious birth complications accompanying with microcir-
culatory changes of different severity [28]. The pathogenesis of vascular changes in 
preterm infants is quite complicated and involves series of biochemical and molecu-
lar reactions (Figure 1). Persistent membrane depolarization results in excessive 
presynaptic glutamate release which follows with a series of cellular changes. The 
activation of NMDA receptors stimulates profound Ca2+ influx, which mediates 
cascades to cell death. Primary energy failure associated with the depletion of oxygen 
prevents oxidative phosphorylation, and the disrupting Na-K pump activity is 
Figure 1. 
The pathogenesis of hypoxic-ischemic encephalopathy [33].
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followed by anaerobic metabolism with accumulation of lactic acid. With the resto-
ration of blood flow, there is a brief period of normalization of cerebral metabolism 
called a latent period. The reperfusion is necessary for the recovery and stopping of 
processes leading to necrotic neuronal injury during the primary phase of injury. 
However when the brain has not recovered from the initial injury, the reperfusion 
can simultaneously cause additional (delayed) injury, and mitochondrial dysfunc-
tion continues. When cerebral ischemia is more acute and prolonged, especially in 
the result of accompanying pathological processes (infection, hereditary factors, 
environmental and other damaging factors), primary injury is followed by second-
ary injury, which is often characterized by subsequent resulting in more serious 
neurological and somatic disintegration in development [29]. Secondary injury is 
often associated with edema of the brain cells. Compensatory restoration of energy 
reactions is followed by the intracellular edema and by more complex inflammatory 
response cascade with the presence of free oxygen radicals [30].
Increased amount of free radicals and nitric oxide (NO), increased synthesis 
of nitric oxide synthase (NOS), activated intercellular adhesion, and apoptosis 
are the tightly connected chains of this pathological process (10–13). However it 
is confirmed that endothelial NOS (eNOS) genesis plays very important role in 
maintaining pulmonary blood flow and preventing pulmonary hypertension. Some 
experimental studies suggested that inhibiting NOS could prevent further brain injury 
[31]. Selective inhibition of NO of neuronal genesis is more promising in the direc-
tion of pathogenetic treatment of HIE in newborn infants [31–33].
The severity of inflammatory processes is correlated with the activation of differ-
ent mediators, especially cytokines and adhesion molecules. These molecules cause 
to the migration of leukocytes to the inflammation center and compact adhesion of 
migrated leukocytes to vascular endothelium [34, 35]. The main stimulus factor for 
the synthesis of inflammatory mediators is the activation of endothelial cells of the 
fetus. Thus, endothelial dysfunction is the main factor that stimulates intracellular 
and vascular adhesion and leads to the activation of fetal leukocytes [36, 37].
There is much to be investigated how the inflammatory response to hypoxia is 
regulated and the complete role of different mediators as well as vasoregulatory, 
anti-inflammatory, and apoptosis molecules under physiological and pathological 
conditions is unknown. The goal of this chapter is to present the results of recent 
investigations about the role of vasoregulatory markers in the formation of micro-
circulatory disorders in hypoxic-ischemic encephalopathy of preterm infants.
3.  Endothelial dysfunction and microcirculatory disorders in HIE of 
preterm infants
Several clinical and experimental studies confirmed the role of endothe-
lial dysfunction in the pathogenesis of hypoxic-ischemic brain injury. The 
prospective clinical trial of Azerbaijan Medical University Neonatology group 
(ACTRN12612000342819) determined that the eNOS activity is declined in the 
background of increased NO concentrations depending on the severity of HIE [38].
The aim of the same study was also to study of the peripheral blood concen-
trations of vasoregulatory mediators of endothelial genesis in the pathogenesis of 
microcirculatory changes in newborn children with the birth asphyxia. It inves-
tigated 240 preterm infants with a high risk of HIE during early neonatal period. 
The main groups of children were classified into four groups depending on the 
degree of the microcirculation changes. The first group included preterm infants 
without microcirculatory changes of the body. The children with mild-degree 
microcirculatory disorders (continued less than 1 day and self-regenerating 
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peroral and acrocyanosis, capillary refilling time duration less than 3 s) were 
included in the second group. The third group consisted of children with moder-
ate microcirculatory disorders (such as peroral and acrocyanosis, marbling of the 
skin, capillary refilling time up to 7 s and continuing from 1 day up to 3 days). 
The fourth group consisted of children with severe microcirculatory disorders 
(acute peroral and acrocyanosis, marbling of the skin continuing more than 
3 days, capillary refilling time with the duration of more than 7 s and continuing 
more than 3 days). The parameters were compared with the data of 2 control 
groups, which consisted of infants without perinatal and neonatal pathologies: 
22 healthy preterm infants were included in control 1 and 30 healthy term infants 
in control 2.
Depending on the magnitude of the microcirculatory defects, the levels of 
vasoregulatory markers included in the study is shown in Table 1. The statistically 
significant reduction in eNOS activity in the first few days of life is noticeable, 
depending on the degree of severity of the microcirculatory disturbances. However 
toward the end of the early neonatal period in mild and moderate group children, 
eNOS concentrations significantly increased compared with children with severe 
microcirculatory changes and control groups.
As shown in Table 1, during severe microcirculation defects, NO synthesis of 
vascular endothelium remains at very low levels. In contrast, NO levels in the early 
days of the neonatal period were noted to significantly increase in infants with 
severe microcirculatory disturbances, and in the dynamics of the neonatal period, 
regardless of the microcirculatory changes severity, it is observed the increase 
of NO concentrations. At the same time, vasoconstrictor endothelin-1 levels rise 
during mild and moderate grades of microcirculation changes, while in infants with 
severe changes, it is reduced. This also proves once again that severe microcircula-
tion disturbances lead to a violation of blood supply both in peripheral and vital 
organs during acute brain damage. We suggest that the lack of adequate levels of 
endothelin-1 synthesis, which is vasoconstrictor mediator of vascular endothelium 
in addition to decreased endothelial NOS activity, becomes one of the main points 
in the pathophysiology of HIE in preterm infants.
The follow-up results of these children included in this study identified sig-
nificant relationships between peripheral endothelial vasoregulatory markers in 
the perinatal period and the formation of developmental disorders at an early age 
[39]. It was found that, in the presence of high concentrations of NO, early eNOS 
activity was insufficient in infants with moderate-to-severe neurodevelopmental 
disorders compared to neonates with mild neurologic changes or without evidence 
of neurological impairment (Table 2). These findings suggest that depressed eNOS 
activity and increased non-endothelial NO synthesis play also important roles in the 
formation of developmental impairments.
It is known that there is a disturbance of vasoregulation in the pathogenesis 
of various pathologies of the HIE and prenatal period [40–42]. Depending on the 
complexity of the pathological process and the degree of morphologic and func-
tional immaturity of the body, hypoxic-ischemic lesions can lead to generalized 
system damage from mild to generalized severe dysfunctions and changes [43–47]. 
Acceleration of blood supply to vital organs during HIE is accompanied by periph-
eral vasospasm. However, the depletion of vascular tone’s regulating mechanisms 
during the severe and long-lasting processes leads to the tissue hypoxia and acidosis 
[40–47]. This often leads to changes in vital organs, especially in brain tissue whose 
results are with changes that cannot be restored.
It is considered that statistically significant increase of NO levels in peripheral 
blood circulation during severe hypoxic changes is due to the exhaustion of endo-
thelial NOS sources and the activation of non-endothelial NO synthesis sources. 
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It is likely that in high endothelin-1 levels in children, mild and moderate changes 
are likely to compensate for an increase in peripheral vein tone and vital organs to 
maintain normal blood circulation. Reduced vasoconstrictor endothelium-1 levels 
in children with severe HIE symptoms are likely to be associated with decreased 
vascular tone and tissue hypoperfusion. In conclusion, the changes of capillary 
blood circulation in the result of endothelial dysfunction have the main role in the 
pathogenesis of hypoxic-ischemic inflammation in preterm infants.
Table 1. 
The level of vasoregulatory indicators in microcirculatory disturbances in children with HIE risk (p<0,05 in 
comparison with children with 0-none of, 1- mild, 2-moderate, 3-severe microcirculatory changes, and with 
# - Control 1, ^ - Control 2 infants).
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